Peptides for Neuropathic Pain & Nerve Damage
Last updated: 2026-03-27
Neuropathic pain — caused by damage or dysfunction of the nervous system itself — affects approximately 7-8% of the UK population. Unlike inflammatory pain that responds well to NSAIDs, neuropathic pain is notoriously difficult to treat, with conditions like diabetic neuropathy, post-herpetic neuralgia, trigeminal neuralgia, and small fibre neuropathy often resistant to conventional analgesics.
Current NHS treatments include gabapentin, pregabalin, duloxetine, and amitriptyline (per NICE CG173), but these achieve adequate relief in only 30-50% of patients and carry significant side effect profiles. This treatment gap has driven interest in novel approaches including peptide-based therapies.
Peptide research for neuropathic pain focuses on neurotrophic peptides that may promote nerve repair, anti-inflammatory peptides that address neuroinflammation, and neuromodulatory peptides that alter pain signal processing.
All information is educational. Neuropathic pain requires specialist assessment and management per NICE CG173.
What this guide is — and what to do first
Peptide research for this condition is interesting, but it is not the first thing to consider. The blocks below cover standard UK care, when to see your GP, what licensed treatments exist, and how the peptide evidence actually stacks up.
Standard care first
NICE NG193 (chronic pain) and CG173 (neuropathic pain) frame UK care. First-line pharmacotherapy: amitriptyline, duloxetine, gabapentin, or pregabalin. Tramadol second-line for acute severe pain only. Topical capsaicin / lidocaine for localised pain. Specialist pain-clinic referral for refractory cases (TENS, spinal cord stimulation in selected cases). Cause-directed treatment: optimise glycaemic control for diabetic neuropathy, B12 replacement, alcohol cessation, etc.
When to speak to your GP
See your GP for new or worsening burning, tingling, numbness, or shooting pain. Urgent same-day for ascending weakness (possible Guillain-Barré), bowel / bladder dysfunction (cauda equina), facial weakness, sudden severe pain after spine injury. Annual diabetic foot check is mandatory in diabetes. Do not start any unlicensed peptide for nerve pain — none have human RCT evidence.
UK-approved treatments for this condition
Cause-directed treatment (glycaemic control, B12 replacement, alcohol cessation). Amitriptyline / duloxetine / gabapentin / pregabalin — NICE first-line. Tramadol — second-line short-term. Topical capsaicin / lidocaine patches for localised pain. NHS pain-clinic referral for refractory cases. TENS, spinal cord stimulation in selected patients. Diabetic foot service for ulcer prevention. No peptide is MHRA-licensed for neuropathic pain.
What the peptide evidence actually says
| Peptide | Human evidence | UK status | Honest verdict |
|---|---|---|---|
| ARA-290 (cibinetide) | Some small Phase 2 in small-fibre neuropathy | Investigational; not licensed in UK | Most advanced peptide for neuropathic-pain specifically; not yet a UK clinical option. |
| BPC-157 | None for neuropathic pain | Unlicensed | Preclinical neuroprotection signal; no human neuropathy trial. |
| Selank | None for neuropathic pain | Unlicensed | Anxiolytic Russian-licensed for unrelated indications; no neuropathic-pain trial. |
| Cerebrolysin | Some trial activity in diabetic neuropathy (licensed jurisdictions) | Not MHRA-licensed | Mixed evidence; not part of UK NHS pathways. |
How Peptides May Help
BPC-157 has demonstrated neuroprotective and neurotrophic effects in preclinical studies, including promotion of nerve regeneration after transection injuries. Its effects on the GABA, dopamine, and serotonin systems — all involved in pain modulation — suggest potential relevance to neuropathic pain mechanisms.
ARA-290 is a non-haematopoietic erythropoietin analogue specifically developed for neuropathic pain. It targets the innate repair receptor (IRR) on neurons and immune cells, promoting nerve repair while reducing neuroinflammation. Small human studies have shown improvements in small fibre neuropathy symptoms.
Selank modulates GABA-ergic pathways involved in pain perception and has anxiolytic effects that may address the significant anxiety and depression that commonly accompanies chronic neuropathic pain.
Researched Peptides
BPC-157
Moderate
Neuroprotective; promotes nerve regeneration in preclinical models; modulates pain-relevant neurotransmitter systems
Selank
Low
GABA modulation and anxiolytic effects; may address pain perception and comorbid anxiety
Semax
Low
ACTH analogue with neuroprotective properties; may support nerve health
TB-500
Low
Anti-inflammatory properties; may reduce neuroinflammation contributing to neuropathic pain
Peptide Comparisons
Current evidence-based treatments for neuropathic pain (gabapentin, pregabalin, duloxetine) target symptom management. Peptide research explores whether nerve repair and neuroinflammation reduction could address underlying causes. ARA-290 is the most clinically advanced peptide for neuropathic pain specifically.
Safety Considerations
No peptides are approved for neuropathic pain treatment in the UK. Patients should not discontinue prescribed neuropathic pain medications in favour of unproven peptide approaches. Gabapentin and pregabalin carry dependence risk and should be managed carefully under GP supervision.
Neuropathic pain can indicate serious underlying conditions (diabetes, B12 deficiency, autoimmune disease, tumour compression) that require proper diagnosis. A thorough neurological assessment is essential before any treatment consideration.
Frequently Asked Questions
Conclusion
Neuropathic pain remains one of the most challenging conditions in clinical medicine, with current treatments achieving adequate relief in only a minority of patients. Peptide research — particularly ARA-290 for nerve repair and BPC-157 for neuroprotection — represents a promising scientific direction. However, all current evidence is preclinical or from small studies, and management should follow NICE CG173 guidelines.
*This information is for educational purposes only. Neuropathic pain requires specialist diagnosis and management. Refer to NICE CG173 for evidence-based neuropathic pain guidance.*
Medical Disclaimer
The information provided on this page is for educational and research purposes only. The peptides discussed are not approved medications for the conditions described. This content does not constitute medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement.
Related Categories
Explore Other Guides
Peptides for Tendon Injuries & Repair
Tendon injuries—whether from sports, repetitive strain, or age-related degeneration—represent some of the most challengi...
Peptides for Fat Loss & Weight Management
The search for effective weight management solutions has led researchers to investigate various peptides that may influe...
Peptides for Muscle Growth & Recovery
The pursuit of enhanced muscle growth, improved recovery, and optimised body composition has driven significant interest...
Peptides for Anti-Ageing & Longevity
The science of ageing has advanced dramatically, moving from inevitable decline to a potentially modifiable process. Pep...
Peptides for Cognitive Enhancement & Brain Health
Cognitive enhancement—improving memory, focus, mental clarity, and brain health—has become a major area of interest in p...
Immunity Peptides: Peptides for Immune Support & Function
"Immunity peptides" is a search term, not a drug class. It is usually used for thymic peptides that influence T-cell dev...
Peptides for Sexual Health & Function
Sexual health encompasses physical function, desire, satisfaction, and psychological wellbeing—all influenced by complex...
Peptides for Joint Health & Cartilage Repair
Joint health issues—including osteoarthritis, cartilage degeneration, and chronic joint pain—affect millions of people w...
Peptides for Sleep Optimization & Sleep Quality
Sleep is fundamental to health, affecting everything from cognitive function and immune defence to metabolic regulation ...
Peptides for Blood Sugar Management & Glycaemic Control
Blood sugar dysregulation affects hundreds of millions of people globally. Type 2 diabetes alone impacts over 530 millio...
Peptides for Anxiety & Stress Reduction
Anxiety and chronic stress affect millions of people worldwide and represent a growing area of unmet clinical need. Whil...
Peptides for Athletic Performance & Recovery
The intersection of peptide science and sports performance has become one of the most actively researched — and debated ...
Peptides for Heart Health & Cardiovascular Support
Cardiovascular disease remains the leading cause of death worldwide, accounting for approximately 17.9 million deaths an...
Peptides for Liver Health & Detoxification
The liver is the body's primary metabolic and detoxification organ, responsible for over 500 essential functions includi...
Peptides for Autoimmune Conditions & Immune Modulation
Autoimmune diseases — conditions in which the immune system mistakenly attacks the body's own tissues — affect approxima...
Peptides for Post-Surgery Recovery & Wound Healing
Post-surgical recovery is a complex physiological process involving haemostasis, inflammation, proliferation, and remode...
Peptides for Skin Pigmentation & Tanning
Skin pigmentation is primarily determined by the production and distribution of melanin — a family of pigments synthesis...
Peptides for Fertility & Reproductive Health
Fertility and reproductive health are regulated by an intricate hormonal network centred on the hypothalamic-pituitary-g...
Peptides for Weight Loss
Weight loss has become one of the most significant public health priorities in the United Kingdom. According to NHS Engl...
Peptides for Diabetes & Blood Sugar Control
Type 2 diabetes is one of the most significant health challenges facing the United Kingdom. Diabetes UK estimates that a...
Peptides for Bodybuilding & Muscle Gain
Bodybuilding and strength sports have long driven interest in compounds that may enhance muscle growth, accelerate recov...
Peptides for Knee Pain & Joint Support
Knee pain is one of the most prevalent musculoskeletal complaints worldwide, affecting an estimated 25% of adults and ac...
Peptides for Back Pain & Spinal Health
Back pain is the leading cause of disability worldwide and one of the most common reasons for GP consultations in the Un...
Peptides for IBS & Digestive Disorders
Irritable bowel syndrome (IBS) affects an estimated 10-15% of the UK population and is the most common functional gastro...
Peptides for Depression & Mood Support
Depression is one of the most prevalent mental health conditions globally, affecting an estimated 5% of the adult popula...
Peptides for PCOS (Polycystic Ovary Syndrome)
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age, with an esti...
Peptides for Chronic Fatigue & CFS/ME
Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME) or ME/CFS, is a complex, debilitating condi...
Peptides for Neuropathy & Nerve Health
Neuropathy — damage or dysfunction of peripheral nerves — affects an estimated 2-3% of the general population, with prev...
Peptides for Thyroid Health & Function
Thyroid disorders are among the most common endocrine conditions in the United Kingdom, affecting an estimated 2-5% of t...
Peptides for Respiratory & Lung Health
Respiratory disease is the third leading cause of death in the United Kingdom, with chronic obstructive pulmonary diseas...
Peptides for Long COVID & Post-Viral Syndrome
Long COVID — formally known as post-COVID-19 syndrome — affects an estimated 1.9 million people in the UK (ONS, 2024). D...
Peptides for Fibromyalgia & Chronic Pain
Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain, fatigue, sleep disturbance, and co...
Peptides for Lyme Disease & Post-Treatment Syndrome
Lyme disease, caused by the spirochaete bacterium *Borrelia burgdorferi* (and related species *B. garinii* and *B. afzel...
Peptides for Erectile Dysfunction & Sexual Performance
Erectile dysfunction (ED) affects an estimated 4.3 million men in the UK, with prevalence increasing significantly after...
Peptides for Infertility: Male & Female Fertility Research
Infertility affects approximately 1 in 7 couples in the UK, with roughly equal contributions from male and female factor...
Peptides for Osteoarthritis & Joint Health
Osteoarthritis (OA) affects over 10 million people in the UK and is the most common form of arthritis, characterised by ...
Peptides for Menopause: Hot Flashes, Bone Loss, Skin & Mood
Menopause affects every woman, typically occurring between ages 45-55 in the UK, with an average age of 51. The decline ...
Peptides for Migraine Prevention
Migraine affects approximately 10 million people in the UK and is the third most common disease globally. While recent C...
Peptides for Disc Degeneration & Back Pain
Intervertebral disc degeneration is the most common cause of chronic lower back pain, affecting an estimated 80% of adul...
Peptides for Frozen Shoulder Recovery
Frozen shoulder (adhesive capsulitis) affects 2-5% of the general population and up to 20% of people with diabetes. It c...
Peptides for Bone Density & Osteoporosis Prevention
Osteoporosis affects approximately 3.5 million people in the UK, causing over 500,000 fragility fractures annually. The ...
Peptides for Cardiovascular Health & Heart Protection
Cardiovascular disease (CVD) remains the UK's leading cause of death, accounting for approximately 160,000 deaths annual...
Peptides for Thyroid Function & Support
Thyroid disorders affect approximately 2-5% of the UK population, with hypothyroidism being far more common than hyperth...
Musculoskeletal Recovery — peptide research hub
Peptide research that touches the musculoskeletal system spans tendon and ligament repair, joint inflammation, cartilage...
Metabolic and Weight — peptide research hub
The metabolic-and-weight space is the most heavily-licensed corner of peptide medicine in the UK — semaglutide (Wegovy /...
Neuro and Mood — peptide research hub
Neuropeptide research is dominated by compounds developed in Russia and Eastern Europe with decades of regional clinical...
Immune and Inflammation — peptide research hub
Immune-modulating and anti-inflammatory peptides are an active research area with thin human-trial data for the conditio...
Skin and Aesthetics — peptide research hub
Cosmetic peptide use splits into two very different categories: topical peptides (GHK-Cu, Matrixyl, Argireline, SNAP-8) ...
Hormonal and Reproductive — peptide research hub
Hormonal and reproductive-health peptides span fertility hormones (gonadorelin, GnRH analogues), menopause-related resea...
Peptides for Hair Growth & Follicle Health
Hair loss affects millions of people worldwide, with androgenetic alopecia (pattern baldness), telogen effluvium, and al...
Peptides for Skin Health & Anti-Ageing
Peptides have revolutionised modern skincare, offering science-backed approaches to anti-ageing, wound healing, and skin...
Peptides for Gut Health & Digestive Repair
Gastrointestinal health is fundamental to overall wellbeing, influencing everything from nutrient absorption and immune ...
Peptides for Wrinkle Reduction & Skin Rejuvenation
Cosmetic peptides have revolutionised the skincare industry, offering targeted mechanisms for addressing different types...
Peptides for Skin Firmness & Collagen Restoration
Skin firmness depends fundamentally on the dermal extracellular matrix—a dense network of collagen, elastin, and glycosa...
Peptides for Wound Healing & Tissue Repair
Wound healing is a complex, multi-phase biological process involving inflammation, proliferation, and remodelling. Chron...
Peptides for Inflammation & Immune Modulation
Chronic inflammation underlies many of the most prevalent health conditions—from autoimmune disorders and cardiovascular...
Peptides for Bone Health & Fracture Recovery
Bone health is a critical concern across the lifespan—from fracture healing in athletes and trauma patients to osteoporo...
Peptides for Anxiety & Stress Management
Anxiety disorders are among the most prevalent mental health conditions globally, affecting approximately 284 million pe...
Peptides for Energy & Metabolic Optimisation
Energy metabolism—the complex system by which cells convert nutrients into usable energy—underlies virtually every aspec...